These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2076527)

  • 1. [The significance of the thrombocyte crossmatching test].
    Korínková P; Vítek A; Prazák J; Sejkorová J
    Cas Lek Cesk; 1990 Dec; 129(51):1621-4. PubMed ID: 2076527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic effectiveness of thrombocyte concentrates in relation to the results of the lymphocytotoxicity test].
    Prazák J; Vítek A; Sejkorová J
    Cas Lek Cesk; 1990 Sep; 129(37):1172-5. PubMed ID: 2224981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombocyte crossmatching: clinical experience with the Capture P-test].
    Böck M; Heim MU; Schleich I; Weindler R; Mepel W
    Beitr Infusionsther; 1990; 26():150-2. PubMed ID: 1703817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The HLA crossmatching test before thrombocyte transfusion. Comparison of 3 methods].
    Májský A; Prazák J
    Vnitr Lek; 1990 Sep; 36(9):873-8. PubMed ID: 2251774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The origin of HLA antigens in thrombocytes].
    Korínková P
    Vnitr Lek; 1989 Sep; 35(9):880-4. PubMed ID: 2683366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombocyte substitution, 2: Thrombocyte preparations and determining the effectiveness of thrombocyte transfusion].
    Anders O; Preussner S; Konrad H
    Z Gesamte Inn Med; 1986 Dec; 41(23):647-51. PubMed ID: 3577256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombocyte substitution. I. Indications and clinical use of thrombocyte transfusion].
    Anders O; Preussner S; Konrad H
    Z Gesamte Inn Med; 1986 Nov; 41(21):592-5. PubMed ID: 3825211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can thrombocyte crossmatching improve the efficiency of platelet transfusion?].
    Weisbach V; Zeiler T; Zingsem J; Musch R; Heuft HG; Eckstein R
    Beitr Infusionsther; 1990; 26():160-2. PubMed ID: 1703820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Failure of therapy with thrombocyte concentrates as a sequela of anti-Kob (3b) antibodies in a patient].
    Májský A; Korínková P; Cermák J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):944-9. PubMed ID: 2419225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HL-A matching in thrombocyte and leukocyte transfusions.
    Matej H; Olearczyk J; Partyka T; Kotlarek-Haus S; Stawarz M; Dzierzkowa-Borodej W
    Arch Immunol Ther Exp (Warsz); 1975; 23(2):181-7. PubMed ID: 807177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
    Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid phase platelet crossmatching versus complement dependent lymphocytotoxicity--clinical utility.
    Lane D; Shivji S; Turner AR
    Prog Clin Biol Res; 1990; 337():59-62. PubMed ID: 2353019
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thrombocyte substitution in acute leukemia. Effect of histocompatibility on the clinical efficacy].
    Kubel M; Freistedt B; Hammer P; Thierbach V; Helbig W; Haustein B; Schultze W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):355-64. PubMed ID: 6179839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
    Levin MD; van der Holt B; de Veld JC; Gratama JW; de Vries W; van't Veer MB
    Vox Sang; 2004 Nov; 87(4):291-8. PubMed ID: 15585026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Substitution of thrombocyte concentrates in polytransfused patients].
    Mempel W; Böck M
    Beitr Infusionsther; 1993; 31():81-5. PubMed ID: 7693269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selection of HLA compatible donors for patients with HLA antibodies].
    Májský A; Korínková P; Kubícková Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):937-43. PubMed ID: 2419224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HLA compatibility and survival of 51 chromium-labeled allogeneic thrombocytes].
    Májský A; Fortýnová J; Vopatová M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):831-7. PubMed ID: 6176508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The incidence of thrombocyte-specific antibodies in multi- and monoparae].
    Winter PM
    Beitr Infusionsther; 1988; 21():296-8. PubMed ID: 2462996
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet crossmatch tests using radiolabelled staphylococcal protein A or peroxidase anti-peroxidase in alloimmunized patients.
    Yam P; Petz LD; Scott EP; Santos S
    Br J Haematol; 1984 Jun; 57(2):337-47. PubMed ID: 6375714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.